Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Low Vitamin D and its receptors might be linked to chronic hair loss in women.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Estrogen deficiency can reduce the enzyme activity needed to activate vitamin D.

Active vitamin D3 might protect hair follicles from radiation damage.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

A mutation in the vitamin D receptor causes severe resistance to vitamin D, affecting bone health but not hair growth.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

New method, hair distribution width (HDW), improves accuracy in diagnosing androgenetic alopecia (AGA).

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

Specific brain and bone imaging findings can help diagnose Trichothiodystrophy.

Finasteride significantly reduces DHT levels in male dogs without affecting testosterone levels, suggesting it could be used to treat benign prostatic hypertrophy in dogs weighing 10 to 50 kilograms.

Men with moderate hair loss had the best spatial thinking, and long-term DHT might affect cognition.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

PCOS patients with autoimmune thyroid disease have lower DHEAS levels.

The study created a new method to test drugs that affect hormone processing in skin.

Many Iraqi women with hirsutism also have hypothyroidism and acne.

Human liver enzyme DHEA ST helps process minoxidil.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Testosterone and dihydrotestosterone slow hair cell growth, while estradiol has no effect.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

A new method accurately measures DHEAS in blood, improving on current tests.

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

Increased DHT formation in skin can cause hair loss, acne, and excessive hair growth, and antiandrogens might treat these conditions.